Esperion to Participate in Upcoming Virtual Investor Conference
Esperion (NASDAQ: ESPR) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 2:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Esperion (NASDAQ: ESPR) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 2:00 p.m. ET. The event will feature a Fireside Chat and 1:1 Meetings. Live audio webcasts will be available on the investor relations section of the Esperion website, with replays archived for 90 days. Esperion is dedicated to lipid management and aims to provide innovative medicines to lower cholesterol for patients with unmet medical needs.
Details
News Market Reaction – ESPR
The recorded move for ESPR in the trading session of this news was -3.22%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANN ARBOR, Mich., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that members of Esperion’s management team will participate in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference.
| Event: | Morgan Stanley 19th Annual Global Healthcare Conference |
| Date: | Thursday, September 9, 2021 |
| Format: | Fireside Chat and 1:1 Meetings |
| Time: | 2:00 p.m. ET |
Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.
ESPERION Therapeutics
ESPERION is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
Investor Contact:
Kaitlyn Brosco
Esperion
corporateteam@esperion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.